What We Do News Haelan 951 research has promising results Last year, Duchenne UK commissioned Professor Steve Winder at Sheffield University to investigate a nutraceutical soy product, called Haelan 951. Haelan 951 has been popular with some DMD families as a perceived way of slowing down disease progression. It has a very unpleasant taste and is expensive. It has never been tested in clinical trials, and the only evidence for its effectiveness is anecdotal. Prof. Steve Winder carried out a study in mice which looked at the various properties in Haelan 951. He then divided them up into different diets, and compared them to each other and to a placebo group. The results clearly showed that one of the diets had a significant and positive effect on the mice. Duchenne UK has now asked Professor Winder to validate and extend these findings in a new set of experiments. We will keep you updated with his progress. Steve winder has produced a poster summarising the findings of this study which you can read here.